Abstract
Chlamydophila pneumoniae (formerly Chlamydia pneumoniae) is an intracellular pathogen responsible for respiratory tract infection. A recent British survey of the microbial aetiology of community-acquired pneumonia (CAP) indicated that C. pneumonia is responsible for 13% of CAP and is the second highest bacterial cause of CAP 1. It has been associated with bronchitis, pharyngitis, sinusitis, myocarditis, endocarditis and coronary artery disease 2. In order to treat C. pneumoniae infections it is first essential to know the efficacy of the available antimicrobial agents against this pathogen. Minimum inhibitory concentration (MIC) tests are used to investigate the in vitro capabilities of antimicrobial agents on bacteria. Therefore, MIC testing of C. pneumoniae needs to be carried out before an antimicrobial agent is used to treat the infection. Culturing of C. pneumoniae must occur before MIC tests can be performed. C. pneumoniae is known to be very difficult to culture and is far more difficult than other chlamydial species 2. Many methods of culturing C. pneumoniae have been proposed with differing cell lines, centrifugation conditions and incubation times. There is no standard method for culturing C. pneumoniae nor for testing the MIC of antimicrobial agents against it. There is no agreement on optimal culture conditions between different Journal of Chemotherapy Vol. 14 n. 3 (312-313) 2002
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
